{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:39:11Z","timestamp":1776847151137,"version":"3.51.2"},"reference-count":67,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100007161","name":"Secretaria de Investigaci\u00f3n y Posgrado del Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","award":["SIP-20240460"],"award-info":[{"award-number":["SIP-20240460"]}],"id":[{"id":"10.13039\/501100007161","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To date, COVID-19 has caused over 772 million cases, with approximately\n7 million deaths, according to the World Health Organization. Therefore, there is a need\nto develop new drugs to address the challenges posed by this disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To propose new antiviral agents based on the natural product curcumin as potential\nprotein-protein interaction inhibitors between the SARS-CoV-2 spike receptor binding domain\n(RBD) and the ACE2 receptor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A curcumin-based virtual screening was performed (Tanimoto coefficient= 0.9), and\nmolecular docking analysis were carried out using the RBD as a receptor. Molecular dynamics\n(MD) using GROMACS were conducted for 120 ns. The SwissADME server was used to predict\npharmacokinetics. To validate predictions, an in vitro enzyme assay measuring the relative inhibition\nof the interaction between the RBD and the ACE2 receptor was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>More than 1300 ligands were evaluated through molecular docking. The docking results\nwere analyzed, and the ligands were classified according to their score and profile of interactions\nwith residues of the RBD of the SARS-CoV-2 S glycoprotein. The top ten with the best scores\nand interactions were selected to verify the commercial availability. The lead compound Cu-1\ndemonstrated significant interactions with the RBD and stability in MD simulations, was acquired\nand evaluated in vitro. Compound Cu-1 inhibited 36 \u00b1 0.7 % the interaction between the SARSCoV-\n2 spike and the ACE2 receptor. In addition, Cu-1 was shown to have an acceptable druglikeness\nand pharmacokinetic profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Curcumin provides a scaffold for identifying novel compounds with potential antiviral\nactivity. Further studies on compound Cu-1 could yield on optimizing its structure to increase\nactivity targeting the RBD of the S glycoprotein.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734064371154250414064157","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:52:02Z","timestamp":1745560322000},"page":"139-149","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Curcumin-Based Virtual Screening Identifies Inhibitors of SARS-CoV-2 Spike Protein and ACE2 Receptor Binding"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8915-7351","authenticated-orcid":true,"given":"Timoteo","family":"Delgado-Maldonado","sequence":"first","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico Nacional, 88710Reynosa, M\u00e9xico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5799-864X","authenticated-orcid":true,"given":"Luis D.","family":"Gonzalez-Morales","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico Nacional, 88710Reynosa, M\u00e9xico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-8488","authenticated-orcid":true,"given":"Gilberto","family":"Vargas-Salas","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico Nacional, 88710Reynosa, M\u00e9xico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8350-4180","authenticated-orcid":true,"given":"Guadalupe","family":"Rojas-Verde","sequence":"additional","affiliation":[{"name":"Instituto de Biotecnolog\u00eda, Facultad de Ciencias Biol\u00f3gicas, Universidad Aut\u00f3noma de Nuevo Le\u00f3n, Nuevo Le\u00f3n CP. 66451, M\u00e9xico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3800-0228","authenticated-orcid":true,"given":"Eyra","family":"Ort\u00edz-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico Nacional, 88710Reynosa, M\u00e9xico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0938-6304","authenticated-orcid":true,"given":"Alma D.","family":"Paz-Gonzalez","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico Nacional, 88710Reynosa, M\u00e9xico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-4167","authenticated-orcid":true,"given":"Gildardo","family":"Rivera","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico Nacional, 88710Reynosa, M\u00e9xico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"Hu B.","year":"2021","unstructured":"Hu B.; Guo H.; Zhou P.; Shi Z.L.; Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol  2021,19(3),141-154","journal-title":"Nat Rev Microbiol"},{"key":"ref=2","year":"2024","unstructured":"World Health Organization (WHO), Data. WHO COVID-19 dashboard. Available from: https:\/\/data.who.int\/dashboards\/covid19\/cases?n=o  (Accessed on: October 15, 2024).2024"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jmv.25726","volume":"92","author":"Liu Z.","year":"2020","unstructured":"Liu Z.; Xiao X.; Wei X.; Li J.; Yang J.; Tan H.; Zhu J.; Zhang Q.; Wu J.; Liu L.; Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol  2020,92(6),595-601","journal-title":"J Med Virol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"974","DOI":"10.2174\/1573409920666230818092445","volume":"20","author":"Hamed M.","year":"2024","unstructured":"Hamed M.; Khalifa M.; El Hassab M.A.; Abourehab M.A.S.; Al Kamaly O.; Alanazi A.S.; Eldehna W.M.; Mansour F.R.; The potential roles of Ficus carica extract in the management of COVID-19 viral infections: A computer-aided drug design study. Curr Computeraided Drug Des  2024,20(6),974-986","journal-title":"Curr Computeraided Drug Des"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"116704","DOI":"10.1016\/j.ejmech.2024.116704","volume":"277","author":"Shawky A.M.","year":"2024","unstructured":"Shawky A.M.; Almalki F.A.; Alzahrani H.A.; Abdalla A.N.; Youssif B.G.M.; Ibrahim N.A.; Gamal M.; El-Sherief H.A.M.; Abdel-Fattah M.M.; Hefny A.A.; Abdelazeem A.H.; Gouda A.M.; Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions. Eur J Med Chem  2024,277,116704","journal-title":"Eur J Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1038\/s41598-024-54886-0","volume":"14","author":"Amer S.A.","year":"2024","unstructured":"Amer S.A.; Al-Zahrani A.; Imam E.A.; Ishteiwy E.M.; Djelleb I.F.; Abdullh L.R.; Ballaj D.; Amer Y.A.; El-Sokkary R.H.; Elshabrawy A.M.; Eskander G.; Shah J.; Raza M.L.; ALsafa, A.M.A.A.; Ali, H.T.; Fawzy, H.M. Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: A multi-national survey study. Sci Rep  2024,14(1),4785","journal-title":"Sci Rep"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"q488","DOI":"10.1136\/bmj.q488","volume":"384","author":"Wise J.","year":"2024","unstructured":"Wise J.; Covid-19: Two rare vaccine side effects detected in large global study. BMJ  2024,384,q488","journal-title":"BMJ"},{"key":"ref=8","year":"2024","unstructured":"The United States Food and Drug Administration (FDA). Coronavirus (COVID-19) | Drugs. Available from:  https:\/\/www.fda. gov\/drugs\/emergency-preparedness-drugs\/coronavirus-covid-19-drugs (Accessed on: October 18, 2024).2024"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"100682","DOI":"10.1016\/j.genrep.2020.100682","volume":"19","author":"Khailany R.A.","year":"2020","unstructured":"Khailany R.A.; Safdar M.; Ozaslan M.; Genomic characterization of a novel SARS-CoV-2. Gene Rep  2020,19,100682","journal-title":"Gene Rep"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/prot.26250","volume":"90","author":"Lubin J.H.","year":"2022","unstructured":"Lubin J.H.; Zardecki C.; Dolan E.M.; Lu C.; Shen Z.; Dutta S.; Westbrook J.D.; Hudson B.P.; Goodsell D.S.; Williams J.K.; Voigt M.; Sarma V.; Xie L.; Venkatachalam T.; Arnold S.; Alfaro Alvarado L.H.; Catalfano K.; Khan A.; McCarthy E.; Staggers S.; Tinsley B.; Trudeau A.; Singh J.; Whitmore L.; Zheng H.; Benedek M.; Currier J.; Dresel M.; Duvvuru A.; Dyszel B.; Fingar E.; Hennen E.M.; Kirsch M.; Khan A.A.; Labrie-Cleary C.; Laporte S.; Lenkeit E.; Martin K.; Orellana M.; Ortiz-Alvarez de la Campa M.; Paredes I.; Wheeler B.; Rupert A.; Sam A.; See K.; Soto Zapata S.; Craig P.A.; Hall B.L.; Jiang J.; Koeppe J.R.; Mills S.A.; Pikaart M.J.; Roberts R.; Bromberg Y.; Hoyer J.S.; Duffy S.; Tischfield J.; Ruiz F.X.; Arnold E.; Baum J.; Sandberg J.; Brannigan G.; Khare S.D.; Burley S.K.; Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first 6 months of the COVID-19 pandemic. Proteins  2022,90(5),1054-1080","journal-title":"Proteins"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1038\/s41401-021-00851-w","volume":"43","author":"Wu C.","year":"2022","unstructured":"Wu C.; Yin W.; Jiang Y.; Xu H.E.; Structure genomics of SARS-CoV-2 and its Omicron variant: Drug design templates for COVID-19. Acta Pharmacol Sin  2022,43(12),3021-3033","journal-title":"Acta Pharmacol Sin"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41419-020-02995-9","volume":"11","author":"Platto S.","year":"2020","unstructured":"Platto S.; Xue T.; Carafoli E.; COVID19: An announced pandemic. Cell Death Dis  2020,11(9),799","journal-title":"Cell Death Dis"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"e03681","DOI":"10.1128\/mBio.03681-20","volume":"12","author":"Day C.J.","year":"2021","unstructured":"Day C.J.; Bailly B.; Guillon P.; Dirr L.; Jen F.E.C.; Spillings B.L.; Mak J.; von Itzstein M.; Haselhorst T.; Jennings M.P.; Multidisciplinary approaches identify compounds that bind to human ACE2 or SARS-CoV-2 spike protein as candidates to block SARS-CoV-2\u2013ACE2 receptor interactions. MBio  2021,12(2),e03681-e20","journal-title":"MBio"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.str.2022.05.006","volume":"30","author":"Zuzic L.","year":"2022","unstructured":"Zuzic L.; Samsudin F.; Shivgan A.T.; Raghuvamsi P.V.; Marzinek J.K.; Boags A.; Pedebos C.; Tulsian N.K.; Warwicker J.; MacAry P.; Crispin M.; Khalid S.; Anand G.S.; Bond P.J.; Uncovering cryptic pockets in the SARS-CoV-2 spike glycoprotein. Structure  2022,30(8),1062-1074.e4","journal-title":"Structure"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41392-020-0195-x","volume":"5","author":"Li J.","year":"2020","unstructured":"Li J.; Zhan P.; Liu X.; Targeting the entry step of SARS-CoV-2: A promising therapeutic approach. Signal Transduct Target Ther  2020,5(1),98","journal-title":"Signal Transduct Target Ther"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"Walls A.C.","year":"2020","unstructured":"Walls A.C.; Park Y.J.; Tortorici M.A.; Wall A.; McGuire A.T.; Veesler D.; Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell  2020,181(2),281-292.e6","journal-title":"Cell"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"Jackson C.B.","year":"2022","unstructured":"Jackson C.B.; Farzan M.; Chen B.; Choe H.; Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol  2022,23(1),3-20","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"Shang J.","year":"2020","unstructured":"Shang J.; Wan Y.; Luo C.; Ye G.; Geng Q.; Auerbach A.; Li F.; Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA  2020,117(21),11727-11734","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"Lan J.","year":"2020","unstructured":"Lan J.; Ge J.; Yu J.; Shan S.; Zhou H.; Fan S.; Zhang Q.; Shi X.; Wang Q.; Zhang L.; Wang X.; Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature  2020,581(7807),215-220","journal-title":"Nature"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"e2122","DOI":"10.1002\/rmv.2122","volume":"30","author":"Tan H.W.","year":"2020","unstructured":"Tan H.W.; Xu Y.M.; Lau A.T.Y.; Angiotensin\u2010converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection. Rev Med Virol  2020,30(5),e2122","journal-title":"Rev Med Virol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"Hoffmann M.","year":"2020","unstructured":"Hoffmann M.; Kleine-Weber H.; Schroeder S.; Kr\u00fcger N.; Herrler T.; Erichsen S.; Schiergens T.S.; Herrler G.; Wu N.H.; Nitsche A.; M\u00fcller M.A.; Drosten C.; P\u00f6hlmann S.; SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell  2020,181(2),271-280.e8","journal-title":"Cell"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","volume":"588","author":"Barnes C.O.","year":"2020","unstructured":"Barnes C.O.; Jette C.A.; Abernathy M.E.; Dam K.M.A.; Esswein S.R.; Gristick H.B.; Malyutin A.G.; Sharaf N.G.; Huey-Tubman K.E.; Lee Y.E.; Robbiani D.F.; Nussenzweig M.C.; West A.P.; Bjorkman P.J.; SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature  2020,588(7839),682-687","journal-title":"Nature"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"671633","DOI":"10.3389\/fmolb.2021.671633","volume":"8","author":"Min L.","year":"2021","unstructured":"Min L.; Sun Q.; Antibodies and vaccines target RBD of SARS-CoV-2. Front Mol Biosci  2021,8,671633","journal-title":"Front Mol Biosci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"104714","DOI":"10.1016\/j.compbiomed.2021.104714","volume":"141","author":"Humayun F.","year":"2022","unstructured":"Humayun F.; Khan A.; Ahmad S.; Yuchen W.; Wei G.; Nizam-Uddin N.; Hussain Z.; Khan W.; Zaman N.; Rizwan M.; Waseem M.; Wei D.Q.; Abrogation of SARS-CoV-2 interaction with host (NRP1) neuropilin-1 receptor through high-affinity marine natural compounds to curtail the infectivity: A structural-dynamics data. Comput Biol Med  2022,141,104714","journal-title":"Comput Biol Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.2147\/DDDT.S292805","volume":"15","author":"Balkrishna A.","year":"2021","unstructured":"Balkrishna A.; Pokhrel S.; Singh H.; Joshi M.; Mulay V.P.; Haldar S.; Varshney A.; Withanone from Withania somnifera attenuates SARS-CoV-2 RBD and host ACE2 interactions to rescue spike protein induced pathologies in humanized zebrafish model. Drug Des Devel Ther  2021,15,1111-1133","journal-title":"Drug Des Devel Ther"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s11010-020-03981-7","volume":"476","author":"Suru\u010di\u0107 R.","year":"2021","unstructured":"Suru\u010di\u0107 R.; Tubi\u0107 B.; Stojiljkovi\u0107 M.P.; Djuric D.M.; Travar M.; Grabe\u017e M.; \u0160avikin K.; \u0160krbi\u0107 R.; Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization. Mol Cell Biochem  2021,476(2),1179-1193","journal-title":"Mol Cell Biochem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/md20030163","volume":"20","author":"Alhadrami H.A.","year":"2022","unstructured":"Alhadrami H.A.; Burgio G.; Thissera B.; Orfali R.; Jiffri S.E.; Yaseen M.; Sayed A.M.; Rateb M.E.; Neoechinulin A as a promising SARS-CoV-2 Mpro inhibitor: In vitro and in silico study showing the ability of simulations in discerning active from inactive enzyme inhibitors. Mar Drugs  2022,20(3),163","journal-title":"Mar Drugs"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/v13071335","volume":"13","author":"ter Ellen B.M.","year":"2021","unstructured":"ter Ellen B.M.; Dinesh Kumar N.; Bouma E.M.; Troost B.; van de Pol D.P.I.; van der Ende-Metselaar H.H.; Apperloo L.; van Gosliga D.; van den Berge M.; Nawijn M.C.; van der Voort P.H.J.; Moser J.; Rodenhuis-Zybert I.A.; Smit J.M.; Resveratrol and pterostilbene inhibit SARS-CoV-2 replication in air\u2013liquid interface cultured human primary bronchial epithelial cells. Viruses  2021,13(7),1335","journal-title":"Viruses"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e06515","DOI":"10.1016\/j.heliyon.2021.e06515","volume":"7","author":"Bhowmik D.","year":"2021","unstructured":"Bhowmik D.; Nandi R.; Prakash A.; Kumar D.; Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis. Heliyon  2021,7(3),e06515","journal-title":"Heliyon"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"112984","DOI":"10.1016\/j.phytochem.2021.112984","volume":"193","author":"Li L.","year":"2022","unstructured":"Li L.; Ma L.; Hu Y.; Li X.; Yu M.; Shang H.; Zou Z.; Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease. Phytochemistry  2022,193,112984","journal-title":"Phytochemistry"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"669642","DOI":"10.3389\/fphar.2021.669642","volume":"12","author":"Xiao T.","year":"2021","unstructured":"Xiao T.; Cui M.; Zheng C.; Wang M.; Sun R.; Gao D.; Bao J.; Ren S.; Yang B.; Lin J.; Li X.; Li D.; Yang C.; Zhou H.; Myricetin inhibits SARS-CoV-2 viral replication by targeting Mpro and ameliorates pulmonary inflammation. Front Pharmacol  2021,12,669642","journal-title":"Front Pharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s13596-021-00576-5","volume":"23","author":"Orege J.I.","year":"2023","unstructured":"Orege J.I.; Adeyemi S.B.; Tiamiyu B.B.; Akinyemi T.O.; Ibrahim Y.A.; Orege O.B.; Artemisia and Artemisia-based products for COVID-19 management: Current state and future perspective. Adv Tradit Med  2023,23(1),85-96","journal-title":"Adv Tradit Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1002\/ptr.8119","volume":"38","author":"Azarkar S.","year":"2024","unstructured":"Azarkar S.; Abedi M.; Lavasani A.S.O.; Ammameh A.H.; Goharipanah F.; Baloochi K.; Bakhshi H.; Jafari A.; Curcumin as a natural potential drug candidate against important zoonotic viruses and prions: A narrative review. Phytother Res  2024,38(6),3080-3121","journal-title":"Phytother Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"31385","DOI":"10.1039\/D0RA03167D","volume":"10","author":"Shanmugarajan D.","year":"2020","unstructured":"Shanmugarajan D.; P P.; Kumar B.R.P.; Suresh B.; Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: Computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets. RSC Advances  2020,10(52),31385-31399","journal-title":"RSC Advances"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s13721-021-00312-8","volume":"10","author":"Suravajhala R.","year":"2021","unstructured":"Suravajhala R.; Parashar A.; Choudhir G.; Kumar A.; Malik B.; Nagaraj V.A.; Padmanaban G.; Polavarapu R.; Suravajhala P.; Kishor P.B.K.; Molecular docking and dynamics studies of curcumin with COVID-19 proteins. Netw Model Anal Health Inform Bioinform  2021,10(1),44","journal-title":"Netw Model Anal Health Inform Bioinform"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1080\/07391102.2020.1868338","volume":"40","author":"Patel A.","year":"2022","unstructured":"Patel A.; Rajendran M.; Shah A.; Patel H.; Pakala S.B.; Karyala P.; Virtual screening of curcumin and its analogs against the spike surface glycoprotein of SARS-CoV-2 and SARS-CoV. J Biomol Struct Dyn  2022,40(11),5138-5146","journal-title":"J Biomol Struct Dyn"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"104818","DOI":"10.1016\/j.compbiomed.2021.104818","volume":"137","author":"Nag A.","year":"2021","unstructured":"Nag A.; Paul S.; Banerjee R.; Kundu R.; In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools. Comput Biol Med  2021,137,104818","journal-title":"Comput Biol Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"105552","DOI":"10.1016\/j.compbiomed.2022.105552","volume":"146","author":"Nag A.","year":"2022","unstructured":"Nag A.; Banerjee R.; Paul S.; Kundu R.; Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study. Comput Biol Med  2022,146,105552","journal-title":"Comput Biol Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.3390\/molecules26226900","volume":"26","author":"Mar\u00edn-Palma D.","year":"2021","unstructured":"Mar\u00edn-Palma D.; Tabares-Guevara J.H.; Zapata-Cardona M.I.; Fl\u00f3rez-\u00c1lvarez L.; Yepes L.M.; Rugeles M.T.; Zapata-Builes W.; Hernandez J.C.; Taborda N.A.; Curcumin inhibits in vitro SARS-CoV-2 infection in vero E6 cells through multiple antiviral mechanisms. Molecules  2021,26(22),6900","journal-title":"Molecules"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/2023.09.28.560070","volume":"28","author":"Septisetyani E.P.","year":"2023","unstructured":"Septisetyani E.P.; Lestari D.; Paramitasari K.A.; Prasetyaningrum P.W.; Kastian R.F.; Anam K.; Santoso A.; Eriani K.; Curcumin and turmeric extract inhibit SARS-CoV-2 pseudovirus cell entry and spike-mediated cell fusion. Pharmacol Toxicol  2023,28,1-27","journal-title":"Pharmacol Toxicol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"10696","DOI":"10.1038\/s41598-024-61662-7","volume":"14","author":"Nicoliche T.","year":"2024","unstructured":"Nicoliche T.; Bartolomeo C.S.; Lemes R.M.R.; Pereira G.C.; Nunes T.A.; Oliveira R.B.; Nicastro A.L.M.; Soares \u00c9.N.; da Cunha Lima B.F.; Rodrigues B.M.; Maricato J.T.; Okuda L.H.; de Sairre M.I.; Prado C.M.; Ureshino R.P.; Stilhano R.S.; Antiviral, anti-inflammatory and antioxidant effects of curcumin and curcuminoids in SH-SY5Y cells infected by SARS-CoV-2. Sci Rep  2024,14(1),10696","journal-title":"Sci Rep"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"O\u2019Boyle N.M.","year":"2011","unstructured":"O\u2019Boyle N.M.; Banck M.; James C.A.; Morley C.; Vandermeersch T.; Hutchison G.R.; Open Babel: An open chemical toolbox. J Cheminform  2011,3(1),33","journal-title":"J Cheminform"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"Morris G.M.","year":"2009","unstructured":"Morris G.M.; Huey R.; Lindstrom W.; Sanner M.F.; Belew R.K.; Goodsell D.S.; Olson A.J.; AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem  2009,30(16),2785-2791","journal-title":"J Comput Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2010","unstructured":"Trott O.; Olson A.J.; AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem  2010,31(2),455-461","journal-title":"J Comput Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"49","author":"Adasme M.F.","year":"2021","unstructured":"Adasme M.F.; Linnemann K.L.; Bolz S.N.; Kaiser F.; Salentin S.; Haupt V.J.; Schroeder M.; PLIP 2021: Expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA. Nucleic Acids Res  2021,49(W1),W530-W534","journal-title":"Nucleic Acids Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1-2","author":"Abraham M.J.","year":"2015","unstructured":"Abraham M.J.; Murtola T.; Schulz R.; P\u00e1ll S.; Smith J.C.; Hess B.; Lindahl E.; GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX  2015,1-2,19-25","journal-title":"SoftwareX"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3390\/pharmaceutics16050613","volume":"16","author":"Delgado-Maldonado T.","year":"2024","unstructured":"Delgado-Maldonado T.; Gonz\u00e1lez-Gonz\u00e1lez A.; Moreno-Rodr\u00edguez A.; Bocanegra-Garc\u00eda V.; Martinez-Vazquez A.V.; de Luna-Santillana E.J.; Pujadas G.; Rojas-Verde G.; Lara-Ram\u00edrez E.E.; Rivera G.; Ligand- and structure-based virtual screening identifies new inhibitors of the interaction of the SARS-CoV-2 spike protein with the ACE2 host receptor. Pharmaceutics  2024,16(5),613","journal-title":"Pharmaceutics"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2174\/0115734064279323231206091314","volume":"20","author":"Delgado-Maldonado T.","year":"2024","unstructured":"Delgado-Maldonado T.; Gonzalez-Morales L.D.; Juarez-Saldivar A.; Lara-Ram\u00edrez E.E.; Rojas-Verde G.; Moreno-Rodriguez A.; Bandyopadhyay D.; Rivera G.; Structure-based virtual screening from natural products as inhibitors of SARS-CoV-2 spike protein and ACE2 receptor binding and their biological evaluation in vitro. Med Chem  2024,20(5),546-553","journal-title":"Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"Daina A.","year":"2017","unstructured":"Daina A.; Michielin O.; Zoete V.; SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep  2017,7(1),42717","journal-title":"Sci Rep"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"111704","DOI":"10.1016\/j.ejmech.2019.111704","volume":"183","author":"Khor P.Y.","year":"2019","unstructured":"Khor P.Y.; Mohd Aluwi M.F.F.; Rullah K.; Lam K.W.; Insights on the synthesis of asymmetric curcumin derivatives and their biological activities. Eur J Med Chem  2019,183,111704","journal-title":"Eur J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1021\/jm070295s","volume":"50","author":"Wen C.C.","year":"2007","unstructured":"Wen C.C.; Kuo Y.H.; Jan J.T.; Liang P.H.; Wang S.Y.; Liu H.G.; Lee C.K.; Chang S.T.; Kuo C.J.; Lee S.S.; Hou C.C.; Hsiao P.W.; Chien S.C.; Shyur L.F.; Yang N.S.; Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem  2007,50(17),4087-4095","journal-title":"J Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/B978-0-12-409547-2.12345-5","author":"Bajusz D.","year":"2017","unstructured":"Bajusz D.; R\u00e1cz A.; H\u00e9berger K.;  Comprehensive Medicinal Chemistry III  2017,329-378","journal-title":"Comprehensive Medicinal Chemistry III"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1038\/s41598-021-81462-7","volume":"11","author":"Jena A.B.","year":"2021","unstructured":"Jena A.B.; Kanungo N.; Nayak V.; Chainy G.B.N.; Dandapat J.; Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: Insights from computational studies. Sci Rep  2021,11(1),2043","journal-title":"Sci Rep"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.bbrep.2021.100969","volume":"26","author":"Harisna A.H.","year":"2021","unstructured":"Harisna A.H.; Nurdiansyah R.; Syaifie P.H.; Nugroho D.W.; Saputro K.E.; Firdayani ; Prakoso C.D.; Rochman N.T.; Maulana N.N.; Noviyanto A.; Mardliyati E.; In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis. Biochem Biophys Rep  2021,26,100969","journal-title":"Biochem Biophys Rep"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1021\/acs.jcim.7b00412","volume":"57","author":"Liu K.","year":"2017","unstructured":"Liu K.; Kokubo H.; Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations: A cross-docking study. J Chem Inf Model  2017,57(10),2514-2522","journal-title":"J Chem Inf Model"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3389\/fphar.2018.00923","volume":"9","author":"Salmaso V.","year":"2018","unstructured":"Salmaso V.; Moro S.; Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview. Front Pharmacol  2018,9,923","journal-title":"Front Pharmacol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"Hollingsworth S.A.","year":"2018","unstructured":"Hollingsworth S.A.; Dror R.O.; Molecular dynamics simulation for all. Neuron  2018,99(6),1129-1143","journal-title":"Neuron"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/bs.apcsb.2015.09.004","volume":"102","author":"Sneha P.","year":"2016","unstructured":"Sneha P.; George Priya Doss C.; Molecular dynamics. Adv Protein Chem Struct Biol  2016,102,181-224","journal-title":"Adv Protein Chem Struct Biol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2174\/1573409919666230726142418","volume":"20","author":"Li T.","year":"2024","unstructured":"Li T.; Yan Z.; Zhou W.; Liu Q.; Liu J.; Hua H.; Discovery of a potential allosteric site in the SARS-CoV-2 spike protein and targeting allosteric inhibitor to stabilize the RBD down state using a computational approach. Curr Computeraided Drug Des  2024,20(6),784-797","journal-title":"Curr Computeraided Drug Des"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.3390\/v13101914","volume":"13","author":"Bormann M.","year":"2021","unstructured":"Bormann M.; Alt M.; Schipper L.; van de Sand L.; Le-Trilling V.T.K.; Rink L.; Heinen N.; Madel R.J.; Otte M.; Wuensch K.; Heilingloh C.S.; Mueller T.; Dittmer U.; Elsner C.; Pfaender S.; Trilling M.; Witzke O.; Krawczyk A.; Turmeric root and its bioactive ingredient curcumin effectively neutralize SARS-CoV-2 in vitro. Viruses  2021,13(10),1914","journal-title":"Viruses"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.addr.2016.04.029","volume":"101","author":"Lipinski C.A.","year":"2016","unstructured":"Lipinski C.A.; Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions. Adv Drug Deliv Rev  2016,101,34-41","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"Veber D.F.","year":"2002","unstructured":"Veber D.F.; Johnson S.R.; Cheng H.Y.; Smith B.R.; Ward K.W.; Kopple K.D.; Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem  2002,45(12),2615-2623","journal-title":"J Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10571-020-00947-7","volume":"42","author":"Lukiw W.J.","year":"2022","unstructured":"Lukiw W.J.; Pogue A.; Hill J.M.; SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol Neurobiol  2022,42(1),217-224","journal-title":"Cell Mol Neurobiol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","volume":"612","author":"Stein S.R.","year":"2022","unstructured":"Stein S.R.; Ramelli S.C.; Grazioli A.; Chung J.Y.; Singh M.; Yinda C.K.; Winkler C.W.; Sun J.; Dickey J.M.; Ylaya K.; Ko S.H.; Platt A.P.; Burbelo P.D.; Quezado M.; Pittaluga S.; Purcell M.; Munster V.J.; Belinky F.; Ramos-Benitez M.J.; Boritz E.A.; Lach I.A.; Herr D.L.; Rabin J.; Saharia K.K.; Madathil R.J.; Tabatabai A.; Soherwardi S.; McCurdy M.T.; Babyak A.L.; Perez Valencia L.J.; Curran S.J.; Richert M.E.; Young W.J.; Young S.P.; Gasmi B.; Sampaio De Melo M.; Desar S.; Tadros S.; Nasir N.; Jin X.; Rajan S.; Dikoglu E.; Ozkaya N.; Smith G.; Emanuel E.R.; Kelsall B.L.; Olivera J.A.; Blawas M.; Star R.A.; Hays N.; Singireddy S.; Wu J.; Raja K.; Curto R.; Chung J.E.; Borth A.J.; Bowers K.A.; Weichold A.M.; Minor P.A.; Moshref M.A.N.; Kelly E.E.; Sajadi M.M.; Scalea T.M.; Tran D.; Dahi S.; Deatrick K.B.; Krause E.M.; Herrold J.A.; Hochberg E.S.; Cornachione C.R.; Levine A.R.; Richards J.E.; Elder J.; Burke A.P.; Mazzeffi M.A.; Christenson R.H.; Chancer Z.A.; Abdulmahdi M.; Sopha S.; Goldberg T.; Sangwan Y.; Sudano K.; Blume D.; Radin B.; Arnouk M.; Eagan J.W.; Palermo R.; Harris A.D.; Pohida T.; Garmendia-Cedillos M.; Dold G.; Saglio E.; Pham P.; Peterson K.E.; Cohen J.I.; de Wit E.; Vannella K.M.; Hewitt S.M.; Kleiner D.E.; Chertow D.S.; SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature  2022,612(7941),758-763","journal-title":"Nature"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1002\/rmv.70009","volume":"34","author":"Dos Reis R.S.","year":"2024","unstructured":"Dos Reis R.S.; Selvam S.; Ayyavoo V.; Neuroinflammation in post COVID-19 sequelae: Neuroinvasion and neuroimmune crosstalk. Rev Med Virol  2024,34(6),e70009","journal-title":"Rev Med Virol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm8010001","volume":"8","author":"Daly A.","year":"2017","unstructured":"Daly A.; Rettie A.; Fowler D.; Miners J.; Pharmacogenomics of CYP2C9: Functional and clinical considerations. J Pers Med  2017,8(1),1","journal-title":"J Pers Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/biomedicines8040094","volume":"8","author":"Saiz-Rodr\u00edguez M.","year":"2020","unstructured":"Saiz-Rodr\u00edguez M.; Almenara S.; Navares-G\u00f3mez M.; Ochoa D.; Rom\u00e1n M.; Zubiaur P.; Koller D.; Santos M.; Mej\u00eda G.; Borobia A.M.; Rodr\u00edguez-Antona C.; Abad-Santos F.; Effect of the most relevant CYP3A4 and CYP3A5 polymorphisms on the pharmacokinetic parameters of 10 CYP3A substrates. Biomedicines  2020,8(4),94","journal-title":"Biomedicines"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064371154250414064157","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/241425\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064371154250414064157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:42:27Z","timestamp":1776843747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/241425\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734064371154250414064157","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}